{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T14:34:19Z","timestamp":1789569259725,"version":"build-2803163510"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"48","license":[{"start":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T00:00:00Z","timestamp":1606262400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004586","name":"Funda\u00e7\u00e3o Carlos Chagas Filho de Amparo \u00e0 Pesquisa do Estado do Rio de Janeiro","doi-asserted-by":"crossref","award":["E-26\/202.931\/2019"],"award-info":[{"award-number":["E-26\/202.931\/2019"]}],"id":[{"id":"10.13039\/501100004586","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Sarcoidosis is a multi-systemic granulomatous disease. Affected individuals can show spontaneous healing, develop remission with drug treatment within 2 years, or become chronically ill. Our main goal was to identify features that are related to prognosis.<\/jats:p>\n            <jats:p>The study consisted of 101 patients, recruited at a single center, who were already diagnosed with sarcoidosis at the start of the study or were diagnosed within 48 months. Ninety individuals were followed-up for at least 24 months and were classified according to clinical outcome status (COS 1 to 9). Those with COS 1\u20134 and COS 5\u20139 were classified as having favorable and unfavorable outcomes, respectively. Unconditional logistic regression analyses were conducted to define which variables were associated with sarcoidosis outcomes. Subsequently, we established a scoring system to help predict the likelihood of a favorable or unfavorable outcome.<\/jats:p>\n            <jats:p>Of our patients, 48% developed a chronic form of the disease (COS 5\u20139). Three clinical features were predictive of prognosis in sarcoidosis. We built a score-based model where the absence of rheumatological markers (1 point), normal pulmonary functions (2 points), and the presence of early respiratory symptoms manifestations (2 points) were associated with a favorable prognosis. We predicted that a patient with a score of 5 had an 86% (95% confidence interval [CI] 74%\u201398%) probability of having a favorable prognosis, while those with scores of 4, 3, 2, 1, and 0 had probabilities of 72% (95% CI 59\u201385%), 52% (95% CI 40\u201363%), 31% (95% CI 17\u201344%), 15% (95% CI 2\u201328%), and 7% (95% CI 0\u201316%) of having a favorable prognosis, respectively. Thus, our easy-to-compute algorithm can help to predict prognosis of sarcoidosis patients, facilitating their management.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000023100","type":"journal-article","created":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T18:58:44Z","timestamp":1606157924000},"page":"e23100","source":"Crossref","is-referenced-by-count":8,"title":["Defining prognosis in sarcoidosis"],"prefix":"10.1097","volume":"99","author":[{"given":"Mariana Carneiro","family":"Lopes","sequence":"first","affiliation":[{"name":"Department of Thoracic Disease"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tha\u00eds Porto","family":"Amadeu","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratories, State University of Rio de Janeiro"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"Ribeiro-Alves","sequence":"additional","affiliation":[{"name":"National Institute of Infectology Evandro Chagas, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia Henrique da","family":"Costa","sequence":"additional","affiliation":[{"name":"Department of Thoracic Disease"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno Rangel Antunes","family":"Silva","sequence":"additional","affiliation":[{"name":"Department of Thoracic Disease"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana Silva","family":"Rodrigues","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratories, State University of Rio de Janeiro"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth Jauhar Cardoso","family":"Bessa","sequence":"additional","affiliation":[{"name":"Department of Thoracic Disease"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo Palermo","family":"Bruno","sequence":"additional","affiliation":[{"name":"Department of Thoracic Disease"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnaldo Jos\u00e9","family":"Lopes","sequence":"additional","affiliation":[{"name":"Department of Thoracic Disease"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5071-6045","authenticated-orcid":false,"given":"Rogerio","family":"Rufino","sequence":"additional","affiliation":[{"name":"Department of Thoracic Disease"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,11,25]]},"reference":[{"key":"R1-20240523","first-page":"149","article-title":"American Thoracic Society\/European Respiratory Society\/World Association of Sarcoidosis and other Granulomatous Disorders","volume":"16","author":"Hunninghake","year":"1999","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"R2-20240523","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ccm.2008.03.013","article-title":"Sarcoidosis around the world","volume":"29","author":"Sharma","year":"2008","journal-title":"Clin Chest Med"},{"key":"R3-20240523","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1183\/09031936.00197808","article-title":"Prevalence of sarcoidosis in Switzerland is associated with environmental factors","volume":"35","author":"Deubelbeiss","year":"2010","journal-title":"Eur Respir J"},{"key":"R4-20240523","first-page":"162","article-title":"Epidemiology of sarcoidosis in Brazil","volume":"2","author":"Bethlem","year":"1985","journal-title":"Sarcoidosis"},{"key":"R5-20240523","first-page":"29","article-title":"Sarcoidosis: epidemiology and prognosis. A 15-year European study","volume":"130","author":"Hillerdal","year":"1984","journal-title":"Am Rev Respir Dis"},{"key":"R6-20240523","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1183\/09031936.00075307","article-title":"Epidemiology of sarcoidosis in Japan","volume":"31","author":"Morimoto","year":"2008","journal-title":"Eur Respir J"},{"key":"R7-20240523","first-page":"438","article-title":"Epidemiological characteristics of sarcoidosis patients in the city of Rio de Janeiro, Brazil","volume":"37","author":"Silva","year":"2011","journal-title":"J Bras Pneumol"},{"key":"R8-20240523","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/oxfordjournals.aje.a009096","article-title":"Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization","volume":"145","author":"Rybicki","year":"1997","journal-title":"Am J Epidemiol"},{"key":"R9-20240523","first-page":"61","article-title":"The frequency of sarcoidosis in Finland and Hokkaido, Japan: a comparative epidemiological study","volume":"12","author":"Pietinalho","year":"1995","journal-title":"Sarcoidosis"},{"key":"R10-20240523","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1164\/ajrccm.164.11.2106001","article-title":"Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS)","volume":"164","author":"Rybicki","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"R11-20240523","first-page":"83","article-title":"ACCESS: a case control etiologic study of sarcoidosis","volume":"22","author":"Semenzato","year":"2005","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"R12-20240523","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1055\/s-0034-1376860","article-title":"Genetics of sarcoidosis","volume":"35","author":"Fisher","year":"2014","journal-title":"Semin Respir Care Med"},{"key":"R13-20240523","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1056\/NEJMra071714","article-title":"Sarcoidosis","volume":"357","author":"Iannuzzi","year":"2007","journal-title":"N Engl J Med"},{"key":"R14-20240523","first-page":"525","article-title":"Prognostic factors predicting the outcome of sarcoidosis: an analysis of 818 patients","volume":"52","author":"Neville","year":"1983","journal-title":"Q J Med"},{"key":"R15-20240523","first-page":"275","article-title":"Features of sarcoidosis associated with chronic disease","volume":"31","author":"Baughman","year":"2015","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"R16-20240523","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.chest.2017.07.008","article-title":"Predictors of mortality in pulmonary sarcoidosis","volume":"153","author":"Kirkil","year":"2018","journal-title":"Chest"},{"key":"R17-20240523","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1136\/bmj.2.5261.1165","article-title":"Prognosis of intrathoracic sarcoidosis in England: a review of 136 cases after five years\u2019 observation","author":"Scadding","year":"1961","journal-title":"BMJ"},{"key":"R18-20240523","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1148\/radiol.2462070712","article-title":"Fleischner society: glossary of terms for thoracic imaging","volume":"246","author":"Hansell","year":"2008","journal-title":"Radiology"},{"key":"R19-20240523","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/echo.13163","article-title":"Right heart involvement in patients with sarcoidosis","volume":"33","author":"Patel","year":"2016","journal-title":"Echocardiography"},{"key":"R20-20240523","first-page":"56","article-title":"Defining the clinical outcome status (COS) in sarcoidosis: results of WASOG Task Force","volume":"28","author":"Baughman","year":"2011","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"R21-20240523","doi-asserted-by":"crossref","first-page":"436","DOI":"10.21037\/atm.2017.08.22","article-title":"Development of scoring system for risk stratification in clinical medicine: a Step-By-Step tutorial","volume":"5","author":"Zhang","year":"2017","journal-title":"Ann Transl Med"},{"key":"R22-20240523","doi-asserted-by":"crossref","first-page":"e7595","DOI":"10.1097\/MD.0000000000007595","article-title":"Multidisciplinary approach and long-term follow-up in a series of 640 consecutive patients with sarcoidosis: cohort study of a 40-year clinical experience at a tertiary referral center in Barcelona, Spain","volume":"96","author":"Ma\u00f1\u00e1","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"R23-20240523","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.rmed.2016.10.003","article-title":"Smoking, obesity and risk of sarcoidosis: a population-based nested case-control study","volume":"120","author":"Ungprasert","year":"2016","journal-title":"Respir Med"},{"key":"R24-20240523","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1164\/rccm.200402-249OC","article-title":"A case control etiologic study of sarcoidosis: environmental and occupational risk factors","volume":"170","author":"Newman","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"R25-20240523","first-page":"351852","article-title":"The prevalence of antinuclear antibodies in patients with sarcoidosis","volume":"2014","author":"Kobak","year":"2014","journal-title":"Autoimmune Dis"},{"key":"R26-20240523","first-page":"119","article-title":"The clinical course of sarcoidosis: presentation, diagnosis, and treatment in a large white and black cohort in the United States","volume":"29","author":"Judson","year":"2012","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"R27-20240523","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1164\/ajrccm.164.10.2104046","article-title":"Clinical characteristics of patients in a case control study of sarcoidosis","volume":"164","author":"Baughman","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"R28-20240523","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1440-1843.2010.01878.x","article-title":"Extrapulmonary involvement in patients with sarcoidosis in Turkey","volume":"16","author":"Okumus","year":"2011","journal-title":"Respirology"},{"key":"R29-20240523","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s12016-014-8450-y","article-title":"The clinical features of sarcoidosis: a comprehensive review","volume":"49","author":"Judson","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"key":"R30-20240523","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1378\/chest.129.5.1246","article-title":"Incidence of pulmonary hypertension and its clinical relevance in patients with sarcoidosis","volume":"129","author":"Handa","year":"2006","journal-title":"Chest"},{"key":"R31-20240523","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1183\/09031936.00175907","article-title":"Clinical predictors of pulmonary hypertension in sarcoidosis","volume":"32","author":"Bourbonnais","year":"2008","journal-title":"Eur Respir J"},{"key":"R32-20240523","doi-asserted-by":"crossref","first-page":"406","DOI":"10.5588\/ijtld.12.0428","article-title":"Sarcoidosis-associated pulmonary hypertension in patients with near-normal lung function","volume":"17","author":"Maimon","year":"2013","journal-title":"Int J Tuberc Lung Dis"},{"key":"R33-20240523","first-page":"275","article-title":"Causes of death in patients with chronic sarcoidosis","volume":"33","author":"Hu","year":"2016","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"R34-20240523","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1183\/09031936.00187410","article-title":"Stage IV sarcoidosis: comparison of survival with the general population and causes of death","volume":"38","author":"Nardi","year":"2011","journal-title":"Eur Respir J"},{"key":"R35-20240523","first-page":"204","article-title":"Two-year prognosis of sarcoidosis: the ACCESS experience","volume":"20","author":"Judson","year":"2003","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"R36-20240523","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1378\/chest.14-1120","article-title":"Racial difference in sarcoidosis mortality in the United States","volume":"147","author":"Mirsaeidi","year":"2015","journal-title":"Chest"},{"key":"R37-20240523","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1471-2466-12-19","article-title":"Increased hospitalizations among sarcoidosis patients from 1998 to 2008: a population-based cohort study","volume":"12","author":"Gerke","year":"2012","journal-title":"BMC Pulm Med"},{"key":"R38-20240523","first-page":"124","article-title":"Hospitalization for patients with sarcoidosis: 1979\u20132000","volume":"23","author":"Foreman","year":"2006","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"R39-20240523","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1183\/09031936.93.06030349","article-title":"Vital prognosis in intrathoracic sarcoidosis wit special reference to pulmonary function and radiological stage","volume":"6","author":"Viskum","year":"1993","journal-title":"Eur Respir J"},{"key":"R40-20240523","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/S0012-3692(15)37649-2","article-title":"Predicting mortality in patients with sarcoidosis awaiting lung transplantation","volume":"124","author":"Shorr","year":"2003","journal-title":"Chest"},{"key":"R41-20240523","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1378\/chest.09-2002","article-title":"Survival in sarcoidosis associated pulmonary hypertension: the importance of hemodynamic evaluation","volume":"138","author":"Baughman","year":"2010","journal-title":"Chest"},{"key":"R42-20240523","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S2213-2600(13)70276-5","article-title":"An integrated clinicoradiological staging system for pulmonary sarcoidosis: a case-cohort study","volume":"2","author":"Walsh","year":"2014","journal-title":"Lancet Respir Med"},{"key":"R43-20240523","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1164\/rccm.2111053","article-title":"Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography","volume":"167","author":"Wells","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"R44-20240523","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1007\/s00330-003-1965-x","article-title":"Sarcoidosis: assessment of disease severity using HRCT","volume":"13","author":"Drent","year":"2003","journal-title":"Eur Radiol"},{"key":"R45-20240523","first-page":"65","article-title":"Non invasive evaluation of the inflammatory activity in sarcoidosis with high-resolution computed tomography","volume":"14","author":"Oberstein","year":"1997","journal-title":"Sarcoidosis Vasc asc Diffuse Lung Dis"},{"key":"R46-20240523","doi-asserted-by":"crossref","first-page":"684","DOI":"10.7326\/0003-4819-156-10-201205150-00004","article-title":"A multidimensional index and staging system for idiopathic pulmonary fibrosis","volume":"156","author":"Ley","year":"2012","journal-title":"Ann Intern Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000023100","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T14:18:43Z","timestamp":1716473923000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000023100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,25]]},"references-count":46,"journal-issue":{"issue":"48","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000023100","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,25]]}}}